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At a time of significant technological change and digitization in the biological sciences, the COVID-
19 pandemic has highlighted again the inequities in the research and innovation ecosystem. 
Based on a consultation with an internationally diverse group of stakeholders from multiple fields 
and professions, and on a broadly representative set of case studies, this report offers a new 
approach to the global governance of genetic diversity and genomic research and innovation.  
 
We recommend that in addition to the many valuable efforts at the macro-policy level and at the 
micro-level of projects, teams and organizations, the global community concerned with 
genetic diversity and genomic research and innovation should devise and implement a 
meso-level initiative that includes three main components:  
 
 
1. First, it should establish a new 
professional capacity to govern research 
and innovation at the meso-level. 
Governance capacity, built through a 
networked community of practice, has the 
benefit of connecting and integrating macro-
level policy intentions with micro-level 
actions. It facilitates a consistent 
professional basis from which local and 
regional level flexibilities can generate new 
norms of reflection that better integrate 
multiple synergies, reconcile tensions, 
recognize inequities, and redress persistent 
inequalities. 
 
2. Second, the global community should 
redouble efforts to build research capacity in 
genomic research and innovation in the 
Global South and for Indigenous Peoples.  
Such an effort should be focused on 
broader programmatic objectives that 
facilitate cross-national and cross-regional 
collaboration, as well as enhancing 
research communities in the Global South 
and in Indigenous communities. Together, 
the twin capacities of governance and 
research can reduce power differentials 
among diverse actors and support crisis-
based imperatives for data openness.  
 
3. Third, we recommend that existing global 
policy frameworks interface with research 
governance and capacity investment. This 
meso-level approach should gain the 
commitment and support from national and 
international policy bodies, embedded within 
existing specific issue-areas (health, 





A new approach, one that can better respond to global crises though more open, inclusive and 
equitable participation in research and innovation, is necessary to resolve the tensions among 
openness, innovation and equity that the current discourse on genetic diversity reiterates. 
Failure to systematically address the social and technical governance challenges will result in 
further fragmentation, inequity and vulnerability for decades to come. Conversely, investing in 
the current historical moment of the pandemic to build twin capacities for meso-level 
governance and research is poised to prevent and/or reduce the impact of future ecological 
crises, while contributing to planetary sustainability and prosperity in the 21st century for current 




1. Context: COVID-19 and governance challenges 
 
 
The acceleration of global research in 
response to the COVID-19 pandemic has 
contributed to unprecedented and rapid 
development and dissemination of data, 
scientific knowledge, technologies and 
products for human health. It has leveraged 
the revolution of genomic science and 
engineering. Yet, the crisis has also 
uncovered that stark differences in human, 
technical and governance capacity across 
countries that have limited inclusivity and 
diversity of research teams and research 
priorities (Johnson, 2020). Acceleration of 
open data sharing has raised concerns about 
disparities in who will benefit from the 
knowledge and products accruing from 
research, data weaponization and misuse, 
and consistency of benefits with the self-
identified needs of historically marginalized 
communities, including communities in the 
Global South and Indigenous communities 
(Aryeetey et al., 2021; Peeling et al., 2020). 
While international collaboration has played 
an important role in understanding the virus, 
competition in vaccine development and 
procurement have also reinforced concerns 
regarding benefit distribution.  
These COVID-19 tensions echo those that 
have been detected in the global governance 
of plant genetic diversity, in the age of big 
data, digitalization and ‘dematerialization’ of 
genetic resources exchange and improved 
genome editing (Welch et al, 2017) (see Box 
1 for more information about plant genetic 
resources).  
 
Convergent governance tensions of 
openness, competition and equity in human 
health and agriculture highlight the need for 
effective governance of genomic data, 
research and innovation to address global 
challenges. Such a governance system must 
navigate among: free and unrestricted 
access to information for science; the control 
of information in order to extract and capture 
economic and reputational value; and the 
integration of considerations of inclusion, 
capacity, sustainability and other societal 
objectives to inform prioritization of needs 
and distribution of benefits to diverse 
beneficiaries.    






The Secretariat of International Treaty on Plant Genetic Resources for Food and Agriculture 
(International Treaty) at the FAO, with support from the Government of Italy, commissioned an 
independent research project to identify the lasting impacts and the institutional and policy 
implications of COVID-19 for genetic diversity and genomic research and innovation, with a 
special focus on open access, global equity and science capacity. This White Paper is the result 
of the independent research project. The recommendations of the White Paper offer an approach 
to better navigate the tensions of openness, innovation and equity.1,2, 3  
 
 
                                               
1 The independent expert consultation did not address specific issues that are currently under consideration in access 
and benefit-sharing negotiations, within the International Treaty and in other genetic resources fora, such as 
terminology and whether genetic sequence data should be included in the scope and operational mechanisms of 
access and benefit-sharing, in the current or enhanced forms.  
2 The scope of this White Paper is genetic diversity and genomics research and innovation, as a continuum of 
collaborative activities where resources are generated, share and used. Given the selection of case studies and the 
focus on governance that participating experts have opted for, this white paper addresses neither the impact of 
intellectual property on, nor the role of private sector in, research and innovation. Along the same lines, the 
recommendations of the white paper do not discuss actual or potential forms of benefit-sharing linked to the 
commercialization of services and products. 




Box 1: Plant genetic resources 
 
The policy and regulatory framework of plant genetic resources exemplifies some of 
the current governance challenges of genetic diversity and genomic research and 
innovation as related to widening scientific research and capacity gaps.  
 
It was designed to pursue global goals such as biodiversity conservation and 
sustainable use, in a context in which informational components were always 
considered in relation to biological materials. It is therefore based on the regulation of 
access to physical samples of genetic material and the allocation of benefit-sharing 
arising from the use of such material (access and benefit-sharing, or ABS).  
 
The increasing use of genetic information and DNA sequences as standalone 
components, along with more accessible and improved genome editing and assembly 
tools, are making crop research and innovation increasingly dependent on digitalized 
information, with a reduced interest in access physical samples. Global policy 
discussions on plant genetic resources are largely polarized around two principles: 
free and unrestricted access to data and information for the benefit of open science, 
and the expansion of ABS requirements to include genetic information. In the 
governance framework of the International Treaty (www.fao.org/plant-treaty/en), 
negotiations to improve the ABS system among participating countries have not yet 
produced an agreement on inclusion of genetic information, mostly due to lack of 
shared values and divergent views between research and industry vis-à-vis 





In parallel, other global governance forums are debating the status of genetic 
sequence data, while developing countries are adding national ABS legislation for 
research using genetic information extracted from genetic resources under domestic 
jurisdictions.  
 
Following the COVID-19 outbreak, plant science stakeholders and private sector have 
taken the example of human health research to reiterate openness as an essential 
prerequisite for genomics research and innovation. Civil society and developing 
countries are amplifying concerns related to benefit-sharing as an essential condition 
for global public goals associated with the management of plant genetic diversity. 
Because science, technology and governance systems do not operate in isolation, 
governance tensions are increasingly apparent among multiple stakeholders, across 
sectors and countries, and at all levels of genomics research and innovation, including 
















2. Macro-, meso- and micro-levels of governance of 
genetic diversity and genomics research and 
innovation 
 
The consultation recognized that three scales 
of governance – macro, meso and micro – are 
relevant for understanding global governance 
of genetic diversity and genomics (GDG) 
research and innovation.  
In short, macro-level level includes global, 
regional and national level agreements, 
legislation, policy and rules.  Micro-level refers 
to the norms, expectations, rules, and 
behaviors that operate at the research and 
innovation level carried out by individuals and 
teams. The meso-level includes the 
organizations, initiatives or networks and the 
actors within them that work together to 
accomplish tasks that further the collective 
goals. The meso-level mediates and 
interrogates the space between macro- and 
micro-levels in two directions: downwards to 
flexibly activate macro-level guidelines at the micro-level and upwards from the micro-level to 
inform broader approaches about local context including capacities, inequities, values and needs.  
 






Box 2: Defining macro-, micro-, and meso-levels of governance 
Governance implies the processes and institutions, both formal and informal, that guide 
and restrain the collective activities of a group. Government is the subset that acts with 
authority and creates formal obligations. Governance does not necessarily need to be 
conducted exclusively by governments. Private firms, associations of firms, universities 
and other research institutions, nongovernmental organizations (NGOs), and 
associations of NGOs all engage in it, often in association with governmental bodies, to 
create governance, sometimes without governmental authority (Keohane and Nye, 
2000). Within this conception of governance, distinctions among macro-, micro-, and 
meso-scale governance are idealized. 
 
Macro-level governance comprises 
legally-based frameworks that operate 
at the national, multi-national or global 
scale. These include frameworks, 
agreements and policies designed to 
provide broad guidance and generate 
benefits across multiple actors. Macro-
governance offers scale and 
coordination of authority, including 
through formal bilateral or multilateral 
agreements such as the International 
Treaty or the Convention on Biological 
Diversity. The benefits of these broad 
governance frameworks are often 
challenged by structural limitations that 
limit flexibility and adaptability for 
responding to technological change, 
social complexities or crises. Similarly, 
the macro-level frameworks are often far 
removed from actors and teams at the 
micro-level, making them less 
responsive to realities of science 
collaboration, for example, and less able 
to address complex social and resource 
inequities. 
 
Micro-level governance comprises 
individual, bilateral or small-scale 
groups of multilateral actors. Micro-level 
governance often occurs at the 
collaboration level. While it offers 
flexibility for learning and innovation and 
may have its own authorities and legally 
binding structures, it lacks scale, 
consistency, and the ability to connect to 
macro level governance. 
 
 Meso-level governance occupies the 
middle ground between macro- and 
micro-levels. It operates through 
formal and informal means to navigate 
and bridge the constraints and 
limitations of the other two levels. 
Actors may include scientists, 
governance experts or other 
stakeholders who are employed in any 
sector. These actors come together in 
a particular domain – such as regional 
collaboration on genomic research – to 
propose, decide on, implement and 
assess the rules, procedures and 
acceptable practices that all 
participants at the micro-level shall 
follow.  Meso-level governance works 
within the macro-level guidance, 
accepting its aims and principles, but 
seeks practical solutions to addressing 
multiple, often conflicting values and 
perspectives, at a local or regional 
level.  The meso-level also values 
micro-level diversity and variability and 
acts to reconcile tensions and 
complexities that arise from 
technological changes (e.g., the big 
data revolution in the life sciences), 
power imbalances, inequities and 
capacity gaps (e.g., genomics 
research ability, financial resources, 
etc.). Meso-level governance:  
● Operates through networks, 
associations, and regional 






generally inclusive of actors from 
multiple backgrounds who represent 
different interests, values, identities 
and legal regimes or contexts. 
● Functions within a particular 
domain, based on substantial 
knowledge and experience, to instill 
knowledge and establish guidelines 
for collaboration. Actors at the 
meso-level often collectively create 
goals and norms that are socially, 
rather than legally, binding. The 
meso-scale does not reject national 
legal regimes, but rather seeks to 
integrate and reconcile multiple 
legal, ethical, technical and 
administrative objectives for feasible 
implementation. 
 
Requires various resources beyond 
financial resources including: 
knowledge and skills, infrastructure, 
venues for discussion, interdisciplinary 
knowledge, and capacity for 
collaboration and governance of 
collaboration in a digital age. Most 
often, these resources are financed by 
multiple funders, which enhances 
collaboration but also adds fragility to 





















The initial postulation of the expert group was that emerging ‘meso-level’ collaborative 
governance approaches might serve as potential pathways to address limitations of global 
frameworks. In collaboration contexts that involve heterogeneous actors (in terms of interest, 
status and capacities), who have limited knowledge about rights and obligations set out in macro-
level frameworks, solutions at the meso-level must go beyond existing or accepted governance 
arrangements to collectively explore alternative governance solutions that better resolve the 
tensions between openness, equity and capacity. In essence, the meso-level must proactively 




3. Limitations of current macro-level and micro-level 
governance frameworks 
 
The expert group discussed and identified limitations of current macro- and micro-level 
frameworks that new governance approach should overcome. 
3.1 Limitations of the macro level  
Existing macro-level governance frameworks of GDG research and innovation are important yet 
insufficient mechanisms for addressing tensions of openness, innovation and equity. Macro-level 
governance frameworks impact GDG research and innovation at the micro-level of scientific and 
collaboration practices through different mechanisms (access to research inputs, data access and 
sharing, intellectual property rights, capacity building) and respond to different challenges (e.g., 
sustainability and equity). With evolving science and technology and the multiplication of 
innovation pathways, this structure becomes unrealistic and burdensome as it fails to account for 
existing normative and organizational resources that are essential in order to mediate between 
macro and micro levels.  
The consultation identified five limitations of macro-level frameworks:  
a. Power imbalances: The uneven 
distribution of capacity, infrastructure 
and financial resources creates power 
imbalances at the macro-level 
resulting in conflictive representation 
of the norms and needs of wealthier 
groups and countries vis-à-vis less 
resource-endowed groups and 
countries. 
b. Exclusionary logic: Current macro-
level frameworks usually rely on a 
narrowly defined set of monetary and 
regulatory incentives and 
disincentives to promote research and 
innovation and manage structural 
inequities and behaviors. Market-
based policy tools (i.e., taxes, 
subsidies) often correct for negative 
externalities at the expense of other 
values –public or common goods, 
societal impact, ethics, and social 
responsibility – that are yet essential 
for the success of meso-level 
initiatives. As a result, framing of 
problems and solutions can 
oversimplify complex social, political, 
economic, environmental, 
technological and scientific contexts. 
c. Policy-science disconnect: GDG 
research and innovation is best 
represented as a complex system in 
which heterogeneous actors from a 
variety of disciplines and sectors 
produce new knowledge, resources 
and innovations through a non-linear, 
feedback-rich process over time in 
which it is increasingly difficult to 
distinguish resource inputs from 
outputs. Nevertheless, current 
macro-level frameworks tend to treat 
research as a linear process in which 
different policy frameworks regulate 
research and innovation inputs and 
outputs. 
d. Incomplete approach to capacity: 
Capacity is best understood as the 
ability to not only access and use 
genomic data but also to contribute 
and use metadata and other types of 
relevant data, participate in building 
the standards and ontologies that 
underlie the digital commons, and 
participate in their governance. 
Current policy approaches often fail 
to account for complex differences in 
capacity. Consequently, demands for 




resource sharing can create barriers 
to collaboration and exchange.  
e. Static design: Even as current 
macro-level policy frameworks slowly 
reorient to respond to changes, 
technological change evolves even 
more rapidly. As a result, macro-level 
frameworks cannot keep up with 
technological change and may not be 
able to accommodate innovative 
collaboration governance 
approaches that balance tensions of 





3.2. Limitations of micro-level 
 
At the micro-level, researchers are generally working in small collaborative teams, some of which 
extend across national boundaries, cultures, disciplines, ways of knowing and interests. They 
often do not understand or recognize macro-level governance initiatives that are intended to guide 
decisions and behaviors at a micro-level. Moreover, while generally collegial, team members often 
vary in reputation and authority, and are not aware of collaboration governance tools that can 
fairly and effectively reconcile possible conflicts in values.   
 
The consultation identified four possible areas of limitation at the micro-level that could be 
addressed by meso-level approaches to governance: 
 
1. Power imbalances. The uneven 
distribution of research capacity, 
resources and infrastructure creates 
power imbalances among researchers 
and teams at the micro-level, favoring 






2. Lack of inclusive knowledge. In the 
current research and innovation 
context organizations prioritize 
categories of scientific expertise 
(natural sciences, engineering and 
technology, medical and health 
sciences, agricultural sciences) and 
often exclude the expertise and 
perspectives of social science as well 
as practitioners and traditional 
knowledge systems. As a result, the 
science-policy interface does not 
effectively represent diverse sets of 
knowledge and ways of knowing. 
 
3. Lack of connection with macro-
level objectives.  Macro-level policy 
guidance or codes of conduct can 
have variable applicability to specific 
research projects that are not mutually 
reinforcing, and that do not build 
persistent and sustained capacity in 
the long run. Additionally, multiple and 
changing macro-level initiatives can 
lead to confusion at the micro-level. 
 
4. Lack of research governance 
expertise. Scientists and teams are 
often unaware of relevant governance 
practices, lack experience or training, 
and do not know where to obtain 










4. Meso-level collaborative governance: exploring 
opportunities in global research initiatives 
 
To understand how the meso-level is 
currently operating, the expert consultation 
identified the following nine case studies as 
potential examples of meso-level 
collaborative research and innovation: 
1) African Orphan Crops Consortium 
2) Bioleft 
3) CARE Principles for Indigeneous 
Data and Governance 
4) The Global Indigenous Data Alliance 
5) CGIAR Big Data Platform 
6) Council for Health Research for 
Development (COHRED) 
7) Just One Gian Lab (JOGL) 
8) ERACoBiotech 
9) Global Alliance for Genomics and 
Health (GA4GH) 
The description of the case studies is 
provided in Appendix A.  
The expert consultation did not undertake in-
depth analysis of each initiative, but rather 
engaged through a series of one- to two- 
hour webinars, each featuring one to three 
case studies. Through presentation and 
discussion, we sought to understand how 
these organizations and networks organize 
and govern themselves through both 
instrumental and normative dimensions of 
governance; incorporate various institutional 
logics; balance tensions of openness, equity, 
and capacity in genetic diversity and 
genomics research and innovation; create 
adaptive learning/responsiveness to new 
context; connect with macro-level 
frameworks and global UN development 
goals.  
The preliminary findings reflect evidence 
presented and initial impressions and 
themes across these case studies, rather 
than the conclusions of exhaustive 
investigation. We articulate the findings in 
three areas, namely: a) tensions; b) COVID-





Across all case studies, common tensions among openness, equity, and capacity are apparent 
and a number of gaps in addressing those tensions emerge.  
 
● Requirements for transparency and 
openness with the goal of increasing 
access to data may drive opposite 
outcomes by excluding organizations 
with limited capacity and unable to 
comply with heavy infrastructure 
requirements. 
● None of the case studies follows a 
comprehensive approach to capacity, 
which was reflected by a division of 
technically-focused initiatives vs. 
equity-focused initiatives, with only 
few addressing both design and 
practice.  
● Some requirements or guidelines 
aimed at advancing equity are so 
stringent that they require extensive 
legal advice and compliance 
monitoring, which only well-funded 
research institutes can afford. 
● Voluntary commitment creates a 
disadvantage for those entities with 




● There is limited transparency about 
(agri)business interests in 
collaborative research initiatives. 
● Sustainability issues for collaborative 
research, such as a mismatch with 
funder goals, or lack of long-term 
donors, are apparent.  
● All case studies are weakly 
connected to global policy, showing a 
stronger connection with micro- 
rather than macro-level actors. While 
this bottom-up approach has 
advantages to promote trust, equity 
and access, there may be tradeoff in 




b) COVID-19 implications and limitations 
 
The experts found that the COVID-19 pandemic provided opportunities for innovation but also 
exacerbated inequities and power imbalances. In many of the case studies, existing gaps and 
tensions were amplified due to COVID response. Common experiences include:  
 
● Increased time pressure to address 
the pandemic, leading to quick 
decision making that may or may not 
consider equity and openness issues 
that would be addressed under 
normal circumstances. 
○ Due to emergency and short 
timeline, genomics research 
and innovation may not move 
towards inclusion, and 
instead generate exclusion 
due to structural default. As 
meso-level solutions rely on 
voluntary participation, this 
can exclude actors with 
limited capacity.  
● With the creation of new ways to 
collaborate due to social distancing, a 
majority of organizations are now 
even more reliant on virtual 
collaboration, which has benefits and 
drawbacks:  
○ Virtual collaboration allows for 
many more diverse 
stakeholders to have access 
to resources and be involved 
in large meetings by removing 
barriers (funding, travel 
capacity, etc.). 
○ However, it is extremely 
difficult to build the trust and 
deep lasting partnerships that 
are needed for sustainability 
with digital collaboration.   
○ Also evident on a global scale 
is a general lack of trust in 





The findings from all the case studies indicated that systems to govern research collaboration are 
either absent or organization-specific. For example, some cases focus entirely on providing 
technical solutions to providing secure repositories and offering options for facilitating openness 
and sharing genomic data (CGIAR Big Data Platform; African Orphan Crops Initiative). Others 
produce statements and guidelines to increase awareness and advocate appropriate practice for 
the use of genomic data in research (CARE), or act as brokers of services and tools for health 
research collaboration (COHRED).  Some large networked international research collaboration 
organizations have relatively nascent research governance systems in place (JOGL) while others 





Three major observations from all case studies point towards inconsistent connections between 
macro-level policy and micro-level collaborative research and innovation.  
● While some research organizations 
articulated well the need for and the 
responsibility to act on collaborative 
governance that addresses data 
challenges, inequities and the 
conflicts associated with international 
research collaboration, some were 
less clear. There is a patchwork of 
approaches to governance of 
research and innovation, with some 
much more deliberate and explicit 
than others. This demonstrates the 
inconsistencies of international 
research governance and the 
absence of organized collective 
learning processes on the conditions 
of success of governance 
arrangements, despite the existence 
of global institutions.   
● One organization, GA4GH, had 
developed complex governance 
system that recognizes the social, 
legal, technical, economic and ethical 
complexities that are embedded in 
genomic research.  GA4GH has 
undertaken an effort to build its own 
capacity to understand and address 
these complexities through a flexible 
but highly skilled, experienced and 
project-specific governance 
approach.   This demonstrates not 
only the need for meso-level 
governance action, but also provides 
an example of a successful effort.  
● Important initiatives such as 
COHRED and CARE, which propose 
principles, norms and procedures on 
research governance, are not 
recognized and integrated into 
macro-level governance systems at 
scale.  As a result, despite some 
isolated examples such as GA4GH, 
there is no systematic uptake and 
integration of important governance 
knowledge and stakeholder 
perspectives in international 
collaborative research. While there 
are many reasons for the 
inconsistencies, this demonstrates 
the limited integration of global norms 
for the effective and equitable 
conduct of research. 
 
 




After further review and discussion, and informed by the cases, the consultation of experts 
developed the Table 1 to articulate the potential for a meso-level approach to address the 
limitations of the macro-level. 
Table 1: Meso-level potential to address the limitations of the macro-level 
 




• Offset governance and normative tensions by reconciling at the 
meso-level. 
• Benefit from more effective contributions of developing countries to 
global policy frameworks. 
• Foster adequate operationalization, implementation, and 
harmonization of existent standards such as the Research Fairness 
Initiative and similar guidelines. These frameworks promise to assure 
more procedural fairness and offer more opportunities to developing 
country researchers to participate in the agenda-setting. 
 
Narrow incentive structure • Contribute to designing and adjusting complementary governance 
tools based on wider incentives. 
 
Policy-science disconnect • Recognize science -- especially in an era of big data -- as a non-
linear, dynamic social process with interrelated inputs and outputs 
• Learn from meso-level governance experiences and build more 
evidence-based assessment of governance outcomes (nexus of 
policy, governance and practice). 
 
Incomplete approach to 
capacity 
• Build the capacity of collaborative actors to embed responsible 
governance approaches into the development and oversight of 
science, integrating equity concerns and managing heterogeneity 
(e.g., of resources, actors, geographies, etc.) directly within the 
process of science and innovation. 
• Take a holistic approach towards science environments and 
strengthen overall research capacities in targeted countries, and at 
the same time harmonize policies with aid donors and research 
funding-organizations in multilateral activities. 
 
Static design • Create the basis for constructive contestation of existing frameworks 
and policy reorientation. 
• Responsive to dynamic developments in science and innovation and 
informing global institutions of those developments in order to design 







A meso-level approach to the governance of genomics research and innovation also generates 
significant potential benefits for the micro-level (Table 2). 
 
Table 2: Meso-level potential to address the limitations of the micro-level 
 
Limits of micro-level Potential meso-level benefits 
 
Power imbalance • Address differences in power among actors that limit participation 
either in collaboration or the governance of research and innovation; 
minimize expectations of reciprocal capacity and contribution as a 
basis for participation. 
• Integrate equity into project goals and methodologies. 
 
Lack of inclusive 
knowledge 
• Harmonize donor-policies with regard to the use of expertise, giving 
preference to local knowledge bases and experts from local 
universities through open agenda-setting processes and the 
formulation of research questions. 
• Benefit from diverse expertise and research engagement in project 
implementation. 
• Harness and reconcile competing institutional logics – academic, 
market, commons, societal impact, ethics/responsibility – in ways that 
enable inclusive, interdisciplinary research and innovation while 




• Improve project implementation by adding specific governance 
expertise (e.g., to reduce tensions among openness, capacity and 
equity issues, and amplify research engagement and uptake). 
Limited connection to 
macro-level 
• Connect projects to macro policy objectives.  







5. Aims and recommendations 
 
Given the observations from the meso-level 
case studies, it is clear that a novel, more 
systematic approach for governing research 
and innovation collaboration is needed to 
better resolve the multiple tensions that have 
arisen and/or been underscored during the 
COVID-19 pandemic. The approach should 
not only proactively address inequities that 
arise during future crises, but also provide a 
stable basis for coordinating and reconciling 
diverse logics, rules, norms, capacities and 
perceptions. It also calls for broader 
recognition of the responsibilities of all actors 
to better reflect on and engage and invest in 
collaborative governance of research and 
innovation. As human-natural systems 
continue to generate immense global 
challenges, it is increasingly important to 
build diverse international research alliances 
that produce new knowledge and science 
and engineering solutions that increase 
resiliency.   
Systematically addressing social and 
technical governance challenges can reduce 
fragmentation, inequity and vulnerability for 
decades to come. The confluence of 
dynamic changes in technology from 
material to data, the limitations of many 
macro-level multilateral agreements, and the 
COVID-19 pandemic provide a critical 
historical juncture and momentum to 
recommend implementation of a new meso-
level governance system for GDG. 
Our recommendations are based on specific 
aims that build from case studies and the 
expertise of participants in the consultation. 
All four aims support our overall goal to 
devise a feasible, systematic meso-level 
collaborative governance system for genetic 
diversity and genomics research and 
innovation that will proactively address 
multiple issues (openness, efficiency, and 
equity) to better respond to global crises. 
 
Aims  
Aim 1:  
Create both research 
and governance 












Aim 2:  
Create a platform to 
integrate knowledge, 
experience and 
insights from existing 
global collaboration 
efforts, networks, 
teams and individuals 
that have begun to 
address meso-level 
governance at the 
project level; 
Aim 3:  








projects and programs 
to help create an 
inclusive governance 
process; 
Aim 4:  
Identify key 
international actors 













To address these aims, the consultation recommends the development of meso-level 
collaborative governance capacity that bridges and complements existing macro-level global 
frameworks while at the same time facilitating international research and innovation at the micro-
level. Development of meso-level governance capacity occurs through the explicit integration of 
existing governance resources, actors and initiatives into a new expert-led platform, and the 
design and implementation of a roadmap that activates macro-informed, meso-level governance 
tools at the micro-level. The meso-level governance capacity will simultaneously address the 
tensions related to global research and innovation, but also build a community of professionals 
who apply specific tools and principles for guiding international research collaboration. The meso-
level effort is enhanced and strengthened by further refinement at the macro- and micro-levels. 
Our vision addresses the macro-micro governance gap, which is visualized in figure 1. 
 
  Figure 1 
 
 
Specifically, we propose undertaking a broad-based effort to build and sustain a global research 
and innovation governance system that includes three main recommendations:  
1) establishment of new professional capacity to govern research and innovation at the meso 
level; 
2) redouble efforts to enhance foundational research capacity in genomic research and 
innovation in the Global South and for Indigenous Peoples; and  
3) garner commitment from international policy bodies that recognize and enable meso-level 












level R&I  
Governance 
Capacity 
From existing, diverse but 
scattered global governance 
expertise to… 
… an integrated platform and 
profession that better bridges macro 
and micro. 












Recommendation 1:  Establish and organize a new globally networked meso-level profession - 
supported by a community of practice - for the governance of research and innovation, including 
the development of complementary governance tools.  
We recommend establishing a new global 
meso-level governance profession that takes 
up the challenge of navigating the space 
between macro- and micro-levels for the 
governance of international collaborative 
research. The new profession would 
establish forums for meeting to review, plan 
and coordinate activities. Actors would 
include individuals from all sectors and 
regions, all of whom would have different 
backgrounds, skills, interests and 
perspectives. All actors would obtain the 
skills and knowledge necessary to 
understand and interrogate complexities of a 
particular research project, program, network 
or initiative.  Initially, diverse actors with 
diverse skills would participate in founding 
the profession and establishing the 
coordination platform.  Over time, curricula 
and experiential training would build skills 
and knowledge base of broader membership 
of research and innovation governance 
experts.    
Additionally, we propose a set of allied policy 
tools that can be used by the profession, 
refined in ways that build governance 
capacity, facilitate development effective 
governance solutions in local contexts, and 
begin to establish critical norms. This 
approach mobilizes and synthesizes existing 
expertise as the basis of the new meso-level 
profession, increasing the international 
capacity of research and innovation 
governance that is responsive to macro-level 
policy on genetic diversity and genomic 
research and innovation, new technological 
changes such as dematerialization and the 
digital revolution and the realities of research 
and innovation.  
1.1 Establishment and Planning: 
Establishment of the profession would be 
built with support from the global macro-level 
on a consciously designed organizational 
and self-governed structure that would be 
acceptable to the diverse community, identify 
principles for collaborative and reflexive 
governance, and develop training and 
knowledge base for the profession.  The 
profession would form an association that 
would provide a central coordinating 
structure, set goals, create necessary 
programs and develop evaluative 
mechanisms to assess effectiveness and 
progress.  The profession would operate as 
a moderately centralized global network, in 
which members are connected to the core 
group of stakeholders, as well as to each 
other in local or regional communities of 
governance practitioners. The meso-level 
organization would facilitate network-wide 
communication and coordination, but also 
facilitate flexible local or regional governance 
discretion.   
As a global meso-level initiative, the 
governance profession would connect to the 
macro-level through support and input from 
United Nations agencies and other 
international organizations. It would also 
acknowledge and integrate existing 
initiatives as important components of and 
sources of input to the profession. At the 
micro-level, it would connect to individual 
researchers and collaborative teams by 
providing contextually relevant expertise and 
input on governance. Because such a 
profession risks becoming a new area of 
power and knowledge inequities, it should be 
confined to create the conditions for 
reflection and learning that can support and 
enhance international collaborative research 
toward goals integrating openness, equity, 
interconnectedness and capacity.  
1.2 Developing the Practice: As a second 




research and innovation governance training 
program. Training would be built on: 1) a 
consolidated curriculum drawing existing and 
emerging knowledge bases in governance 
and decision-making, global policy regimes, 
collaboration and team science, ethics and 
inclusive learning; 2) governance case 
studies to build knowledge; 3) conflict 
resolution, evaluation and monitoring; and 4) 
experiential learning such as through 
temporary placement in major government 
research programs, companies, national 
labs, science-policy interface bodies or 
public agencies. Core competencies could 
include: data management/digital skills; 
science policy; innovation and intellectual 
property law; Indigenous and traditional 
rights and knowledge; research governance 
and administration; research ethics; team 
science and collaboration, conflict 
negotiation, and evaluation. We recommend 
the establishment and curation of an online 
resource library of global governance 
materials to provide a knowledge repository 
and reference valuable to both training and 
practice.  The resource library would include 
the stock of guidelines and codes of conduct 
(e.g., FAIR (https://www.go-fair.org/fair-
principles/), CARE (https://www.gida-
global.org/care), industry codes of conduct, 
etc.), case studies and other assessments, 
grey literature, open-source academic 
literature, among other items. 
Research and innovation governance 
training would be designed in modules and 
offered online. Specific training modules 
would be developed by sub-community 
governance experts in collaboration with key 
stakeholders. For example, a module on 
data governance could be developed by 
practitioners or academics in collaboration 
with stakeholder experts on FAIR or CARE 
principles. Finally, as with most professional 
groups, it would include a learning 
component such that would collect and 
disseminate best practices, exemplary case 
studies and relevant literature. It would also 
organize decentralized interactions of actors 
through engagement in collective inquiry 
processes. It would finally undertake 
evaluative efforts on both formative and 
summative bases as a means of continued 
improvement. 
1.3 Researcher Training:  As a third step, 
the governance profession would develop a 
researcher-level certification program 
designed to inform researchers in genomics 
and data about the ethical, power and value 
complexities of global research and 
innovation. We envision this researcher-level 
training to be offered through a system such 
as CITI, which operates world-wide for 
investigator-level training on research with 
human subjects and animals 
(https://about.citiprogram.org/en/series/hum
an-subjects-research-hsr/). Training would 
integrate understanding of existing codes of 
conduct and best practices related to 
navigating the tension between, for example, 
openness, intellectual property rights and 
ethical use of data and resources. The 
training would be informed by existing codes 
of conduct and the relevant grey and 
academic literatures. Individuals who 
successfully complete the governance 
training would receive global research and 
innovation governance certification 
recognized by key external bodies (see 
recommendation 3). For individuals involved 
in international research, particularly those 
involved with research with the individuals, 
teams and organizations in the Global South 
or Indigenous communities, certification 
would be required prior to the 
commencement of research funding and 
commencement of research activities. The 
ultimate goals of such training are to 
1) develop norms of acceptable behavior 
related to genomics and genetic diversity, 
research and innovation globally and 2) 
complement the meso-level governance 
profession with micro-level researcher-level 





Recommendation 2: Revise investment strategy for research capacity in the Global South and 
for Indigenous Peoples to integrate diverse capacities for genetic diversity and genomics 
research and innovation. 
Diverse individuals, communities, 
organizations, institutions, networks, 
countries, and regions each may offer certain 
kinds of capacity in GDG research and 
innovation while lacking other kinds of 
capacity.  Integration of these capacities—
and an emphasis on the value of human 
capital development over a narrower focus 
on the development of any one product or 
technology— is necessary to effectively 
reconcile different logics and tensions and to 
overcome structural inequities that appear in 
the process of science and innovation, and 
requires an awareness and willingness of 
scientists, stakeholders and other experts to 
work together to identify needs, govern data 
collection and use, and distribute benefits. 
Increasing research capacities in the Global 
South and Indigenous communities is critical 
for enhancing participation of low-income 
countries and marginalized groups in GDG 
research and innovation. Yet investment is 
often targeted at the micro-level, in middle-
income countries, to specific projects that are 
often isolated from each other. Moreover, 
current macro-level approaches in GDG that 
decouple resource access from benefit 
sharing tend to avoid the need to build 
capacity to use data. Viable access to data 
for research depends on infrastructure and 
human capital development, being part of the 
research process, and determining 
permissions and protocols for sharing data, 
not solely on making the data available or 
‘open.’ Failure to revise the current grant-
based approach to building research 
capacity in the Global South and Indigenous 
communities will continue to perpetuate 
knowledge divides, rather than reduce them. 
A meso-level approach would help in 
developing a more programmatic approach 
to investment in research capacity that 
emphasizes building flexible research 
infrastructure and matching it with diverse, 
core competencies depending on research 
needs as defined by those in the 
communities. A coordinated investment 
program would identify research topics and 
areas for investment and fund a portfolio of 
projects that target distinct needs across 
countries and regions in the Global South 
and for Indigenous Peoples.  We believe the 
revised investment portfolio should support 
the development of fundamental research 
capacity through a programmatic approach 
in which individual projects contribute to and 
draw on ever-increasing blocks of knowledge 
and skills. We believe that the WHO 
Pandemic Influenza Preparedness 
framework 
(https://www.who.int/influenza/pip/en/) to 
invest in clinical capacity provides an early 
example of this approach. The SING 
Consortium 
(https://www.singconsortium.org/), which 
enhances capacity of Indigenous peoples in 
genomic research and leadership, provides 
another example, and has led to efforts such 
as the Native BioData Consortium 
(https://nativebio.org/), the first nonprofit 
research institute led by Indigenous 
scientists and tribal members in the United 
States. 
While acknowledging structural inequity and 
divide that hamper equal participation in 
research efforts across countries and actors, 
the meso-level approach would help point to 
the importance of the ability to engage 
collaboratively in a collective inquiry process. 
This dimension transcends the North-South, 
well-endowed/marginalized group. The 




capacity building efforts in a more integrated 
way with the overall aim to increase 
cooperative capacities of actors to engaging 
in joint action by setting common objectives 
that better reflect the diversity of normative 
expectations of the group and collectively 
explore a diversity of solutions to their 
collective action problems. 
Funds would encourage and incentivize 
program-based collaboration among 
partners with different research capacities, 
and enhance human capital and 
infrastructure necessary to be an effective 
collaborative partner. In sum, the meso-level 
approach would increase the research ability 
of the individual, team, country such that it is 
in a more authoritative position to: 1) 
prioritize research that meets the needs of 
their communities; 2) effectively develop and 
contribute to research; 3) negotiate the terms 
of collaboration and resource use, plan 
processes and develop policy; and 
4) steering deliberative governance of 
convergence and divergence within the 
collaborative activity.
 
Recommendation 3: Interface existing global policy frameworks with research governance and 
capacity investment. 
In this section, we explore how existing 
macro-level governance can understand and 
implement our recommendations for 
developing meso-level governance capacity. 
As our case studies show, efforts to connect 
meso- with macro-governance are rare. This 
gap also hints, however, to a productive 
context where much potential resides to 
innovate the global governance for science, 
technology and innovation. Whereas 
Recommendation 2 is focused on research 
capacity, we focus here in Recommendation 
3 on the need for investment in research 
governance capacity. 
Historically, efforts to innovate global 
governance have been limited to specific 
issue-areas related to emerging technology 
(e.g., the Global Observatory for Genome 
Editing (and link); see Appendix B, 
‘Intellectual foundations’). To the best of our 
knowledge, no mechanism is in place that 
specifically embeds meso-level governance 
at the global level and explicitly recognizes 
the importance of research governance as 
the nexus of policy, knowledge and practice. 
As a consequence, current experiences may 
be of limited value to incubate, test and scale 
up our recommendations, and by extension, 
implementation may need innovative 
solutions.  
Going forward, we envision the support of 
governance capacity for research and 
innovation within existing global frameworks 
on issues-specific areas. The rationale is to 
build upon existing policy experience about 
how different governance arrangements 
shape relevant outcomes in specific 
contexts, and rely on existing frameworks to 
obtain political, material and financial support 
to governance capacity at the meso-level for 
research and innovation (e.g., by funding a 
governance capacity training program or 
coordinating in-kind support). 
However, the initiative would have to go 
beyond the current conception of capacity to 
implement obligations of international 
treaties. Deliberations of international fora on 
capacity often result in generic lists of areas 
(e.g., legal-administrative, technical) where 
capacity of developing countries should be 
built. Even when accompanied by time-
bound mechanisms of coordination and 
implementation, such deliberations rarely, if 
ever, produce an actual assessment of 
needs and outcomes, with the result of 




dependent approach to capacity. These 
deficiencies may be the result of a narrow 
conception of capacity as merely functional 
to implementation of treaty macro-objectives, 
and of the artificial distinction between 
capacity providers (e.g., skillful individuals or 
resource-endowed institutions in OECD 
countries) and recipients (e.g., individuals 
and organizations in developing countries). 
Under this option, governance is addressed 
as a stand-alone objective, detached from 
existing, issue-specific global frameworks 
and thus less dependent on issue-specific 
variables. We consider that a commitment to 
meso-level governance capacity, as an 
objective and a process on its own standing 
geared towards collaboration, would change 
the current framing and dynamics of the 
policy discussion at the global level— e.g., 
within the genetic diversity policy 
frameworks. It would create the necessary 
space for governance to be a legitimate 
objective to be integrated into existing, issue-
specific, macro-level objectives (e.g., 
conservation, equity) and delegated to 
meso-level for implementation through 
increased learning capacity of actors 
engaged in collaborative actions. 
State and non-State actors would engage in 
apprehending governance capacity as a goal 
and governance capacity would become the 
actual object of multilateral commitment. In 
our views, this new approach to capacity 
would also create an opportunity for 
constructive contestation of current 
outcomes by actors and regime shifting 
towards realignment of existing institutions or 
creation of new institutions to support 
cooperation. A multilateral commitment to 
capacity could gradually prompt policy 
reorientation at all levels. Such reorientation 
would produce significant adjustment of 
behavior, institutional rules and standards, 
national and international policies, and 
ultimately build new coherence between 
research, innovation, and equity. Currently, 
COHRED has developed an early version of 
a global learning system for institutional and 
global research governance through its 
Research Fairness Initiative (rfi.cohred.org). 
Once the support to governance and 
research capacity is nested in existing 
frameworks, a new, cross-cutting and stand-
alone multilateral commitment to 
collaborative governance supported by 
capacity building and meso-level 
approaches may also be explored. The 
commitment may be formalized through, by 
way of example, a joint declaration or a 
collaborative platform among the different 
conventions and fora, where research 
governance is addressed as a stand-alone 
objective, still connected to existing, issue-
specific global frameworks but less 






6. Implementation steps 
 
The expert consultation did not reflect on 
the implementation plan. Initial ideas are 
provided as a basis for further discussion. 
1. Globally networked meso-level 
profession  
As a first step, and with support from the 
global macro-level, a diverse core group of 
stakeholders from representative countries 
would convene to establish the mission, 
vision and structure of the profession.  These 
founding individuals would come from 
multiple countries and multiple disciplines, 
experiences, backgrounds, and positions, 
with the purpose of building and sustaining a 
research governance platform and research 
governance profession that can interpret and 
adapt to change, address complexity, 
reconcile conflict and generate opportunity.  
The platform would sponsor meetings (virtual 
and face-to-face) to develop a roadmap for 
establishing the multiple components of the 
meso-level profession. The roadmap would 
set out plans for the gradual development of 
governance capacities to inform, review and 
guide international collaborative research 
projects, programs, and initiatives. The 
roadmap would articulate the mechanisms 
by which governance could stimulate 
collaborative management of genetic 
diversity, genomics research and innovation, 
including in times of crisis, while also 
addressing the tensions inherent within and 
between existing macro-level policies, codes 
of conduct, and research community and 
non-research stakeholder beliefs, values and 
needs.  
2. Investment strategy for research 
capacity 
Under the initiative of a group of leading 
donors, a network of donors and qualified, 
diverse representatives of research 
stakeholders in developing countries, would 
be established. The network would establish 
permanent dialogue and share experiences 
and concerns related to the funding of 
integrated capacities. It would gradually 
elaborate principles, goals and criteria for 
investment strategy in research capacity. 
This body of guidelines should integrate 
existing standards on research fairness but 
specifically follow a meso-level approach.  
Such body of guidelines would gradually be 
imported into donor strategies and then used 
as the basis for continuous feedback, 
adjustment and specification by the network, 
and for promoting meso-level coalitions.  
3. Interface with existing global policy 
frameworks  
A commitment for developing meso-level 
governance capacity for genetic diversity, 
research and innovation could be built in 
international frameworks (e.g., the Plant 
Treaty), initially by creating regular 
opportunities for dialogue between the 
decision-making bodies of such frameworks, 
and the core group of stakeholders under #1 
and the network under #2.  
The benefits of such dialogue would be 
reciprocal. By way of example, the roadmap 
for the development of governance capacity 
could be responsive to developments 
occurring at the macro-level and macro-level 
policy making would be informed by the 
multiple components of the meso-level 
profession. Coordination of investment 
strategies with the funding strategies of 
international frameworks (e.g., the Plant 









Initiative and aims Actors involved 
African Orphan Crops Consortium works to ensure 
the availability of nutritious orphan crops to 
consumers in Africa by promoting their production, 
through the adoption of modern breeding methods for 
crop improvement purposes and training of farmers. 
Research institutions, corporations/industry, 
individual researchers and breeders 
 
Bioleft is a community for research, co-design and 
implementation of tools for conservation, 
dissemination and open and collaborative 
improvement of seeds. 
Network of breeders -small farmers, organic 
growers, academics and researchers, public 
institutions 
CARE Principles for Indigenous and Data 
Governance 
 
Indigenous researchers, data practitioners, 
and; 
policy activists advocating for Indigenous 
Data Sovereignty 
 
The Global Indigenous Data Alliance (GIDA) are a set 
of people and purpose-oriented guidelines and 
community, reflecting the crucial role of data in 
advancing Indigenous innovation and self-
determination.  
Indigenous researchers, data practitioners, 
and; 
policy activists advocating for Indigenous 
Data Sovereignty 
 
CGIAR Big Data Platform uses big data to solve 
agricultural development problems faster, better and 
at greater scale through tools, best practices, and 
consultation. 
Agricultural research centers, universities, 
private industry, core group is 15 existing 
CGIAR centers and programs and over 70 
external partners 
Council on Health Research for Development 
(COHRED) goal is to maximize the potential of 
research and innovation to deliver sustainable 
solutions to the health and development problems of 
people living in low and middle-income countries.  
Governments, research institutions and 
councils, civil society and the media, NGOs 
and for-profit corporations working in research 
and innovation for health. 
Just One Giant Lab (JOGL) digital social platform that 
helps people, organizations, and industry, to sync 
onto fixing urgent and important societal problems 
using open science, responsible innovation and 
continuous learning. 
Academic labs, corporations/industry, 
schools/ universities, startups, philanthropic 
foundations, NGOs, individuals; and public 
institutions 
  
ERA CoBiotech’s goal is to strengthen the field of 
Biotechnology through encouraging cooperation and 
coordination of different national and regional 
research programs, promoting systems biology and 
Researchers, industry representatives, 
research / innovation funders, representative 




synthetic biology as technology drivers to speed up 
research and innovation in industrial biotechnology. 
Global Alliance for Genomics and Health (GA4GH) 
aims to accelerate progress in genomic research and 
human health by cultivating a common framework of 
standards and harmonized approaches for effective 








Appendix B: Intellectual foundations 
 
The initiatives set forth in this White Paper are informed and inspired by several literatures: meso-
level network governance, institutional theory, responsible research and innovation, and policy 
design.  
 
We are interested in linking the macro-level global institutions establishing principles and 
mechanisms for the governance of access and use of digital sequence data and genomics 
research in general, with micro-level behavior of researchers. Our decision to focus on meso-
level governance comes both from the apparent implementation gap and from the literature on 
meso-level institutions that cuts across numerous social science disciplines including economics, 
institutional theory, network theory, management science and public administration (Banjade et 
al., 2007; Faist, 2010 ; Grimmelikhuijsen et al., 2017; Kim and Croidieu, 2016; Ortbals et al., 2012; 
Rasmussen et al., 2019; Schenk & Uiterkamp, 2007; Tummers, 2020). Network structure, 
composition and relationships play an important role in meso-level governance because they  
integrate actors horizontally, but also connect them vertically (Klijn et al., 2013; Newig & Pahl-
Wostl, 2010; Torfing, 2005). According to Torfing, governance networks are:  
 
“(1) relatively stable horizontal articulations of interdependent, but operationally 
autonomous actors who (2) interact with one another ... (3) within a regulative, normative, 
[and cognitive] ... framework that is (4) self-regulating within limits set by external forces 
and which (5) contributes to the production of public purpose.” (2005:307) 
 
Networks are recognized as important forms of multi-level governance (Provan and Kenis, 2007; 
Bodin and Crona, 2009). They can facilitate collective action and innovation (Powell and Grodal, 
2005; Lejano and de Castro, 2014) through four functions (Berthet and Hickey, 2018): 
Connecting; Framing; Knowledge brokering; and Exploring. This latter function points to the 
importance of learning for the success of collective action. Focus on governance cannot simply 
consist in selecting the best known organizational model for a specific problem (De Schutter, 
Lenoble, 2010). It should also help generate alternatives beyond an existing set of solutions by 
stimulating production and analysis of information about an ongoing intervention by the actors 
involved themselves (Ansell, Bartenberger, 2016).  
 
Institutional theory has increasingly been applied to understand and explain how individuals, 
organizations and fields combine and integrate multiple, often conflicting, institutional logics 
(Battilana et al., 2009; Lawrence et al., 2011), which are frameworks that orient actors to interpret 
reality and act in social situations (Thornton, 2004; Greenwood, 2011). As the number of 
institutional logics embedded in a social context increases, individuals are subject to greater 
institutional complexity and need to address conflicts and tensions that stem from diversity of 
values, beliefs, and approaches. Scientific research, including GRG research and innovation, is 
institutionally complex because it is embedded in a variety of institutional logics stemming from 
different regulatory regimes, disciplinary norms, systems of ethics, and field cultures (Dunn & 
Jones, 2010; Kraatz & Block, 2008).  Concrete efforts to proactively reconcile conflicting logics 
can improve the effectiveness of social processes.  
 
Building on the International Relations literature on ‘transnational communities’, for our purposes 
global collaboration research and innovation initiatives are governance ‘communities’ with 
transnational scope (Stone, 2008; Djelic and Quack, 2010). These communities execute and 




jurisdictions. The responsible research and innovation (RRI) literature focuses on the inclusion of 
broader economic, ethical and social considerations in the decision-making process in science 
not only downstream at the innovation level but also ex ante, by shaping and steering the 
innovation process. RRI is often referred to, broadly, as an activity that takes into account the 
societal dimensions of emerging technology, science and innovation. This overarching definition 
serves as a starting point to enhance reflexivity and bring together diverse actors who share the 
motivation and values to build bridges between the content and context (be it social, political, 
material) of knowledge-making in 21st century contemporary science. In doing so, RRI helps 
redress the long-standing deficits of modernity, of several centuries long, that have falsely treated 
science as apolitical and devoid of social and cultural context.  RRI and related global governance 
frameworks thus strive for sociotechnical integration, and democratization of science and 
innovation. They usually take the form of deliberations and enhanced learning process to better 
anticipate and reflect the diversity of values, needs and concerns in society related to this or that 
technology (Istratii and Hasan, 2019; Fransmen et al., 2018). One example at the international 
level is the call for an international network of scholars and organizations (a global observatory) 
to support a new kind of conversation on genome editing and seek “broad societal consensus” on 
the norms that should guide research (Jasanoff and Hurlburt, Nature, March 2018). The CARE 
principles respond to the same kind of logic of providing normative guidance to research practices. 
RRI enables meso-level governance of collective arrangements and practices of science by 
moving towards more collaborative, reflexive and co-productive practices of research and 
innovation (Calvert and Martin, 2009) that embed governance aims in ongoing internal decision-
making processes of research (Landeweerd et al., 2015). The challenge is to increase the 
collective capacities of the different actors within global initiatives to cooperate in the pursuit of 
the wider general interest.  
 
Just as meso-level network governance frames the context of our initiatives, the policy-design 
literature provides a foundation for components of our recommended way forward. In particular, 
we focus on the policy-tools approach. Policy tools are specific instruments that convey or require 
information, authority, resources or organizations for accomplishing specific policy aims (Howlett, 
2009; IPBES, n.d.; Schneider & Ingram, 1990). Because governance systems are complex, this 
approach recognizes that to achieve desired outcomes, it is necessary for policy designers to 
select coherent mixtures of policy tools, techniques and methods (Huttunen et al., 2014; Rogge 
and Reichard, 2016). The policy tools approach to policy design draws on different sources of 
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